title: Upper respiratory tract infections.
abstract: The routine, easiest-to-treat URI PTEs utilized 1.1 office visits during the course of a PTE. This patient group also received 0.05 tests, 0.66 laboratory and pathology services, and 0.05 medical/surgical procedures during the course of a PTE averaging 9.6 days in length. The major cost driver for URI PTEs was physician visits. Approximately 62% of URI PTEs produced a claim for prescription drug therapy. Overall, URI patients were treated with 1.3 prescriptions per PTE. Thirty-two percent of all PTEs received one-drug group and 17.5% received two-drug group treatments. Amoxicillin was the most commonly used drug for these patients.
authors.forename: L
authors.initials: L
authors.lastname: Adamovic
authors.forename: J A
authors.initials: JA
authors.lastname: Gricar
authors.forename: D G
authors.initials: DG
authors.lastname: Cave
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use*; D019411:Clinical Laboratory Techniques / Q000191:economics; D017281:Cost of Illness; D004363:Drug Utilization / Q000191:economics; D017050:Episode of Care; D019538:Health Care Surveys; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D008875:Middle Aged; D009819:Office Visits / Q000706:statistics & numerical data; D012042:Registries; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics*; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents